Yayın:
Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis

Basit Görünüm
dc.contributor.authorBoz, Cavit
dc.contributor.authorÖzakbaş, Serkan
dc.contributor.authorTerzi, Murat
dc.contributor.authorTürkoğlu, Recai
dc.contributor.authorAkman, Gülşen
dc.contributor.authorEfendi, Hüsnü
dc.contributor.authorAkçalı, Aylin
dc.contributor.authorTuncer, Alaettin
dc.contributor.authorYüceyar, Nur
dc.contributor.authorSoysal, Aysun
dc.contributor.authorKöseoğlu, M.
dc.contributor.authorBalcı, Belgin Petek
dc.contributor.authorSevim, Serhan
dc.contributor.authorAltıntaş, Ayşe
dc.contributor.authorÇilingir, Vedat
dc.contributor.authorDemirkıran, Meltem
dc.contributor.authorKızılay, Ferah
dc.contributor.authorAltunrende, Burcu
dc.contributor.buuauthorTuran, Ömer Faruk
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNöroloji Ana Bilim Dalı
dc.date.accessioned2023-08-08T13:31:23Z
dc.date.available2023-08-08T13:31:23Z
dc.date.issued2017-10
dc.descriptionBu çalışma, 25-28, Ekim 2017 tarihlerinde Paris[Fransa]’ de düzenlenen 7. Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipMerck & Company
dc.description.sponsorshipNovartis
dc.description.sponsorshipBayer AG
dc.description.sponsorshipTeva Pharmaceutical Industries
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis
dc.description.sponsorshipAmericas Comm Treatment & Res Multiple Sclerosis
dc.identifier.citationBoz, C. vd. (2017). ''Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis''. Multiple Sclerosis Journal, 23(Supplement 3), 327-328.
dc.identifier.endpage328
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.issueSuplement 3
dc.identifier.startpage327
dc.identifier.urihttps://journals.sagepub.com/toc/msja/23/3_suppl
dc.identifier.urihttp://hdl.handle.net/11452/33415
dc.identifier.volume23
dc.identifier.wos000413730202068
dc.indexed.wosSCIE
dc.indexed.wosCPCIS
dc.language.isoen
dc.publisherSage Puplications
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalMultiple Sclerosis Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNeurosciences & neurology
dc.subject.wosClinical neurology
dc.subject.wosNeurosciences
dc.titleReal world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis
dc.typeOther
dc.type.subtypeMeeting Abstract
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nöroloji Ana Bilim Dalı
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications